The Pharmaceutical Device Prisma(®) Skin Promotes in Vitro Angiogenesis through Endothelial to Mesenchymal Transition during Skin Wound Healing

Glycosaminoglycans are polysaccharides of the extracellular matrix supporting skin wound closure. Mesoglycan is a mixture of glycosaminoglycans such as chondroitin-, dermatan-, heparan-sulfate and heparin and is the main component of Prisma(®) Skin, a pharmaceutical device developed by Mediolanum Fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Belvedere, Raffaella, Bizzarro, Valentina, Parente, Luca, Petrella, Francesco, Petrella, Antonello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578006/
https://www.ncbi.nlm.nih.gov/pubmed/28757565
http://dx.doi.org/10.3390/ijms18081614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578006/
https://www.ncbi.nlm.nih.gov/pubmed/28757565
http://dx.doi.org/10.3390/ijms18081614

Ejemplares similares